{
    "zip": "1560",
    "sector": "Healthcare",
    "fullTimeEmployees": 1136,
    "longBusinessSummary": "Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumumab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Arzerra for treating CLL. Its products under development include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; tisotumab vedotin for treating cervical, ovarian, and solid cancers; HuMax-IL8 for treating advanced cancers; HexaBody-DR5/DR5, DuoBody-CD3x5T4, JNJ-63898081, JNJ-70218902, DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; and DuoBody-CD3xCD20 and DuoHexaBody-CD37 for treating hematological malignancies. The company's products under development also comprise Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; HuMax-IL8 for treating advanced cancers; JNJ-61186372 for the treatment of non-small-cell lung cancer; JNJ-63709178 and JNJ-67571244 to treat acute myeloid leukemia; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating Parkinson's disease. In addition, it has approximately 20 active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with Immatics Biotechnologies GmbH to research and develop next-generation bispecific immunotherapies for treating multiple cancer indications; CureVac AG for the research and development of differentiated mRNA-based antibody products; AbbVie for the development of epcoritamab; and collaborations with BioNTech, Janssen, Novo Nordisk A/S, BliNK Biomedical SAS, and Bolt Biotherapeutics, Inc. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.",
    "city": "Copenhagen",
    "phone": "45 70 20 27 28",
    "country": "Denmark",
    "companyOfficers": [],
    "website": "https://www.genmab.com",
    "maxAge": 1,
    "address1": "Kalvebod Brygge 43",
    "industry": "Biotechnology",
    "ebitdaMargins": 0.43205002,
    "profitMargins": 0.36335,
    "grossMargins": 1,
    "operatingCashflow": 1188999936,
    "revenueGrowth": 0.34,
    "operatingMargins": 0.39433,
    "ebitda": 3416250112,
    "targetLowPrice": 37,
    "recommendationKey": "hold",
    "grossProfits": 10111000000,
    "freeCashflow": 633625024,
    "targetMedianPrice": 47,
    "currentPrice": 36.31,
    "earningsGrowth": 0.675,
    "currentRatio": 11.997,
    "returnOnAssets": 0.08565,
    "numberOfAnalystOpinions": 7,
    "targetMeanPrice": 46.36,
    "debtToEquity": 2.053,
    "returnOnEquity": 0.14451,
    "targetHighPrice": 56,
    "totalCash": 18742999040,
    "totalDebt": 437000000,
    "totalRevenue": 7906999808,
    "totalCashPerShare": 14.332,
    "financialCurrency": "DKK",
    "revenuePerShare": 12.0909,
    "quickRatio": 11.997,
    "recommendationMean": 2.9,
    "exchange": "NMS",
    "shortName": "Genmab A/S",
    "longName": "Genmab A/S",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EST",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-18000000",
    "underlyingSymbol": null,
    "quoteType": "EQUITY",
    "symbol": "GMAB",
    "underlyingExchangeSymbol": null,
    "headSymbol": null,
    "messageBoardId": "finmb_665704",
    "uuid": "5594dda7-7736-3abc-bcfd-5fa676c317ff",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 4.066,
    "beta3Year": null,
    "enterpriseToEbitda": 9.411,
    "52WeekChange": null,
    "morningStarRiskRating": null,
    "forwardEps": 7.96,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 654193024,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "totalAssets": null,
    "bookValue": 32.551,
    "sharesShort": 2082541,
    "sharesPercentSharesOut": 0.0032,
    "fundFamily": null,
    "lastFiscalYearEnd": 1609372800,
    "heldPercentInstitutions": 0.07187,
    "netIncomeToCommon": 2872999936,
    "trailingEps": 0.6611,
    "lastDividendValue": null,
    "SandP52WeekChange": null,
    "priceToBook": 1.1154804,
    "heldPercentInsiders": 0,
    "nextFiscalYearEnd": 1672444800,
    "yield": null,
    "mostRecentQuarter": 1632960000,
    "shortRatio": 4.23,
    "sharesShortPreviousMonthDate": 1636934400,
    "floatShares": 1293577251,
    "beta": 0.686773,
    "enterpriseValue": 32148652032,
    "priceHint": 2,
    "threeYearAverageReturn": null,
    "lastSplitDate": 1525132800,
    "lastSplitFactor": "5:1",
    "legalType": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": 0.679,
    "priceToSalesTrailing12Months": 3.020095,
    "dateShortInterest": 1639526400,
    "pegRatio": 0.24,
    "ytdReturn": null,
    "forwardPE": 4.561558,
    "lastCapGain": null,
    "shortPercentOfFloat": null,
    "sharesShortPriorMonth": 1430950,
    "category": null,
    "fiveYearAverageReturn": null,
    "previousClose": 37.44,
    "regularMarketOpen": 36.31,
    "twoHundredDayAverage": 41.412125,
    "trailingAnnualDividendYield": null,
    "payoutRatio": 0,
    "volume24Hr": null,
    "regularMarketDayHigh": 37.01,
    "navPrice": null,
    "averageDailyVolume10Day": 292610,
    "regularMarketPreviousClose": 37.44,
    "fiftyDayAverage": 40.7194,
    "trailingAnnualDividendRate": null,
    "open": 36.31,
    "averageVolume10days": 292610,
    "expireDate": null,
    "algorithm": null,
    "dividendRate": null,
    "exDividendDate": null,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 36.26,
    "currency": "USD",
    "trailingPE": 54.92362,
    "regularMarketVolume": 691436,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 23879890944,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 406290,
    "dayLow": 36.26,
    "ask": 0,
    "askSize": 900,
    "volume": 691436,
    "fiftyTwoWeekHigh": 49.07,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": null,
    "fiftyTwoWeekLow": 30.1,
    "bid": 36.25,
    "tradeable": false,
    "dividendYield": null,
    "bidSize": 900,
    "dayHigh": 37.01,
    "regularMarketPrice": 36.31,
    "preMarketPrice": null,
    "logo_url": "https://logo.clearbit.com/genmab.com"
}